An update on intracerebral stem cell grafts

References

• McGovern Institute. Brain disorders: by the numbers | mcgovern institute for brain research at MIT [Internet]. McGovern Inst. 2014. [[Last accessed 2018 Jan 18]. http://mcgovern.mit.edu/brain-disorders/by-the-numbers.
   Google Scholar
• Harvard NeuroDiscovery Center. The challenge of neurodegenerative diseases [Internet]. Harvard neurodiscovery cent. 2018. [cited 2018 Jan 30]. Available from: https://neurodiscovery.harvard.edu/challenge
   Google Scholar
• Lindvall O, Barker RA, Brüstle O, et al. Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell [Internet]. 2012;10:151–155.
   PubMed Web of Science ®Google Scholar
• Bhattacharya N, Stubblefield P, editors. Human fetal tissue transplantation [Internet]. London: Springer London; 2013.
   Google Scholar
• Tajiri N, Duncan K, Antoine A, et al. Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. Front Syst Neurosci [Internet]. 2014;8:116.
   Google Scholar
• Meamar R, Dehghani L, Ghasemi M, et al. Stem cell therapy in stroke: a review literature. Int J Prev Med [Internet]. 2013;4:S139–46.
   PubMedGoogle Scholar
• Lim J, Jeong C, Jun J, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther [Internet]. 2011;2:38.
   PubMed Web of Science ®Google Scholar
• Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med [Internet]. 2013;368:610–622.
   PubMed Web of Science ®Google Scholar
• Altarche-Xifro W, Di Vicino U, Muñoz-Martin MI, et al. Functional rescue of dopaminergic neuron loss in parkinson’s disease mice after transplantation of hematopoietic stem and progenitor cells. EBioMedicine [Internet]. 2016;8:83–95.
   PubMed Web of Science ®Google Scholar
• Niclis JC, Turner C, Durnall J, et al. Long-distance axonal growth and protracted functional maturation of neurons derived from human induced pluripotent stem cells after intracerebral transplantation. Stem Cells Transl Med [Internet]. 2017;6:1547–1556.
   PubMed Web of Science ®Google Scholar
• Ambasudhan R, Dolatabadi N, Nutter A, et al. Potential for cell therapy in Parkinson’s disease using genetically programmed human embryonic stem cell-derived neural progenitor cells. J Comp Neurol [Internet]. 2014;522:2845–2856.
   PubMed Web of Science ®Google Scholar
• Glover LE, Tajiri N, Weinbren NL, et al. A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived stem cells. Transl Stroke Res [Internet]. 2012;3:90–98.
   PubMed Web of Science ®Google Scholar
• Lescaudron L, Rossignol J, Dunbar GL. Stem cells and neurodegenerative diseases. Boca Raton: CRC Press/Taylor & Francis; 2014.
   Google Scholar
• Yasuhara T, Matsukawa N, Hara K, et al. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson’s disease. J. Neurosci. [Internet]. 2006;26:12497–12511.
   PubMed Web of Science ®Google Scholar
• Ghosh B, Zhang C, Smith GM. Bridging between transplantation therapy and neurotrophic factors in Parkinson’s disease. Front Biosci (Elite Ed) [Internet]. 2014;6:225–235.
   PubMedGoogle Scholar
• Nikkhah G, Cunningham MG, Cenci MA, et al. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci [Internet]. 1995;15:3548–3561.
   PubMed Web of Science ®Google Scholar
• Kriks S, Shim J-W, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature [Internet]. 2011;480:547–551.
   Google Scholar
• Kirkeby A, Grealish S, Wolf DA, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep [Internet]. 2012;1:703–714.
   PubMed Web of Science ®Google Scholar
• Tarazi FI, Sahli ZT, Wolny M, et al. Emerging therapies for Parkinson’s disease: from bench to bedside. Pharmacol Ther [Internet]. 2014;144:123–133.
   PubMed Web of Science ®Google Scholar
• Institute AR. Study to assess the safety and effects of autologous adipose-derived svf cells in patients with Parkinson’s disease. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01453803;
   Google Scholar
• StemGenex. Outcomes data of adipose stem cells to treat Parkinson’s disease. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT02184546;
   Google Scholar
• Lander E, Inc. CSN. Safety and clinical outcomes study: svf deployment for orthopedic, neurologic, urologic, and cardio-pulmonary conditions. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01953523;
   Google Scholar
• Cambridge U of, University L, University C, et al. TRANSEURO open label transplant study in Parkinson’s disease. 2012. [cited 2018 Jan 30]. Available form: https://ClinicalTrials.gov/show/NCT01898390;
   Google Scholar
• Fegert JM, Fangerou H, Trapp T. Implanted minds: the Neuroethics of intracerebral stem cell transplantation and deep brain stimulation. Bielefeld: Transcript Verlag; 2011.
   Google Scholar
• Glud AN, Bjarkam CR, Azimi N, et al. Feasibility of three-dimensional placement of human therapeutic stem cells using the intracerebral microinjection instrument. Neuromodulation [Internet]. 2016;19:708–716.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Thanos CG, Goddard M, et al. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis [Internet]. 2006;23:471–480.
   PubMed Web of Science ®Google Scholar
• Mu S, Wang J, Zhou G, et al. Transplantation of induced pluripotent stem cells improves functional recovery in huntington’s disease rat model. Singla DK, Editor. PLoS One [Internet]. 2014;9:e101185.
   PubMed Web of Science ®Google Scholar
• Baig AM. Designer’s microglia with novel delivery system in neurodegenerative diseases. Med Hypotheses [Internet]. 2014;83:510–512.
   PubMed Web of Science ®Google Scholar
• C V B, Thanos CG, Skinner SJM, et al. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington’s disease. Cell Transplant. [Internet]. 2007;16:987–992.
   PubMed Web of Science ®Google Scholar
• Lee JY, Xu K, Nguyen H, et al. Stem cell-induced biobridges as possible tools to aid neuroreconstruction after CNS injury. Front Cell Dev Biol [Internet]. 2017;5:51.
   PubMedGoogle Scholar
• A-C B-L, Rémy P, J-P N, et al. Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet [Internet]. 2000;356:1975–1979.
   PubMed Web of Science ®Google Scholar
• Keene CD, Sonnen JA, Swanson PD, et al. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology [Internet]. 2007;68:2093–2098.
   PubMed Web of Science ®Google Scholar
• Cicchetti F, Saporta S, Hauser RA, et al. Neural transplants in patients with Huntington’s disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci [Internet]. 2009;106:12483–12488.
   PubMed Web of Science ®Google Scholar
• A-C B-L, Gaura V, Brugières P, et al. Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol [Internet]. 2006;5:303–309.
   PubMed Web of Science ®Google Scholar
• Jiang W, Büchele F, Papazoglou A, et al. Multitract microtransplantation increases the yield of darpp-32-positive embryonic striatal cells in a rodent model of Huntington’s disease. Cell Transplant. [Internet]. 2011;20:1515–1527.
   PubMed Web of Science ®Google Scholar
• University of California D. A pre-cellular therapy observational study in early Huntington’s disease.2013. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01937923;
   Google Scholar
• Kim M, Lee S-T, Chu K, et al. Stem cell-based cell therapy for Huntington disease: a review. Neuropathology [Internet]. 2008;28:1–9.
   PubMed Web of Science ®Google Scholar
• Choi K-A, Choi Y, Hong S. Stem cell transplantation for Huntington’s diseases. Methods [Internet]. 2017;133:104–112.
   Google Scholar
• Guzik A, Stroke Epidemiology BC, Management RF. Continuum (Minneap. Minn). [Internet]. 2017;23:15–39.
   Google Scholar
• National Heart, Lung and BI (NHLBI). Stroke [Internet]. 2018. [cited 2018 Jan 18], Bethesda, MD: National Heart, Lung, and Blood Institute.
   Google Scholar
• Goyal M, Menon BK, Van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (London, England) [Internet]. 2016;387:1723–1731.
   PubMed Web of Science ®Google Scholar
• Casals JB, Pieri NCG, Feitosa MLT, et al. The use of animal models for stroke research: a review. Comp Med [Internet]. 2011;61:305–313.
   Google Scholar
• Rodrigues MCO, Glover LE, Weinbren N, et al. Toward personalized cell therapies: autologous menstrual blood cells for stroke. J Biomed Biotechnol [Internet]. 2011;2011:194720.
   PubMedGoogle Scholar
• C V B, Tajima Y, Trojanowski JQ, et al. Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neuroreport [Internet]. 1998;9:3703–3709.
   PubMed Web of Science ®Google Scholar
• C V B, Kaneko Y, Maki M, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev [Internet]. 2010;19:439–452.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Dailey T, Weinbren NL, et al. The battle of the sexes for stroke therapy: female- versus male-derived stem cells. CNS Neurol Disord Drug Targets [Internet]. 2013;12:405–412.
   PubMed Web of Science ®Google Scholar
• Hicks AU, Lappalainen RS, Narkilahti S, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci [Internet]. 2009;29:562–574.
   PubMed Web of Science ®Google Scholar
• Chiang YH, Lin SZ, C V B, et al. Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation. J Cereb Blood Flow Metab [Internet]. 1999;19:1329–1335.
   PubMed Web of Science ®Google Scholar
• C V B, Lind JG, Dillon-Carter O, et al. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res [Internet]. 2004;1010:108–116.
   PubMed Web of Science ®Google Scholar
• C V B, Skinner SJM, Geaney M, et al. CNS grafts of rat choroid plexus protect against cerebral ischemia in adult rats. Neuroreport [Internet]. 2004;15:1543–1547.
   PubMed Web of Science ®Google Scholar
• Hara K, Matsukawa N, Yasuhara T, et al. Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion. J Neurosci Res [Internet]. 2007;85:1240–1251.
   PubMed Web of Science ®Google Scholar
• Hara K, Yasuhara T, Maki M, et al. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol [Internet]. 2008;85:318–334.
   PubMed Web of Science ®Google Scholar
• Tajiri N, Acosta S, Glover LE, et al. Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. Arumugam T V., Editor. PLoS One [Internet]. 2012;7:1–10.
   Web of Science ®Google Scholar
• Tajiri N, Quach DM, Kaneko Y, et al. Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines. Mezey E, Editor. PLoS One [Internet]. 2014;9:e91408.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Tajiri N, Shinozuka K, et al. Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke [Internet]. 2013;44:3473–3481.
   PubMed Web of Science ®Google Scholar
• C V B, Evans A, Yu G, et al. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res [Internet]. 2005;1048:116–122.
   PubMed Web of Science ®Google Scholar
• Savitz SI. Developing Cellular Therapies for Stroke. Stroke [Internet]. 2015;46:2026–2031.
   PubMed Web of Science ®Google Scholar
• C V B, Hess DC. New hope for stroke patients: mobilization of endogenous stem cells. CMAJ [Internet]. 2006;174:954–955.
   PubMed Web of Science ®Google Scholar
• Nelson PT, Kondziolka D, Wechsler L, et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol [Internet]. 2002;160:1201–1206.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Wechsler L, Goldstein S, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology [Internet]. 2000;55:565–569.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Steinberg GK, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg [Internet]. 2005;103:38–45.
   PubMed Web of Science ®Google Scholar
• Bang OY. Clinical trials of adult stem cell therapy in patients with ischemic stroke. J Clin Neurol [Internet]. 2016;12:14–20.
   PubMed Web of Science ®Google Scholar
• Kalladka D, Sinden J, Pollock K, et al. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet (London, England) [Internet]. 2016;388:787–796.
   PubMed Web of Science ®Google Scholar
• Nagpal A, Choy FC, Howell S, et al. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Res Ther [Internet]. 2017;8:191.
   PubMed Web of Science ®Google Scholar
• University WM, Center U of NTHS. Autologous bone marrow mesenchymal stem cell transplantation for chronic stroke. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01714167;
   Google Scholar
• Southern Medical University C, Foshan TSPH of ND of, Guangzhou TFPH of HD, et al. Autologous bone marrow stromal cell and endothelial progenitor cell transplantation in ischemic stroke. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01468064; 2011.
   Google Scholar
• Paz I de IHU La. Reparative therapy in acute ischemic stroke with allogenic mesenchymal stem cells from adipose tissue, safety assessment, a randomised, double blind placebo controlled single center pilot clinical trial. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01678534;
   Google Scholar
• Institute AR, Instituto de Medicina Regenerativa SA de C V. Study to assess the safety and effects of autologous adipose-derived stromal cells in patients after stroke. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01453829;
   Google Scholar
• Zhang L, Li Y, Zhang C, et al. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke [Internet]. 2011;42:1437–1444.
   PubMed Web of Science ®Google Scholar
• National Center for Injury Prevention and Control. National center for injury prevention and control [Internet]. 2010, Atlanta, GA: Centers for Disease Control and Prevention.
   Google Scholar
• Hayashi T, Kaneko Y, Yu S, et al. Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res [Internet]. 2009;1280:172–177.
   PubMed Web of Science ®Google Scholar
• Carroll JE, Borlongan CV. Adult stem cell therapy for acute brain injury in children. CNS Neurol Disord Drug Targets [Internet]. 2008;7:361–369.
   PubMed Web of Science ®Google Scholar
• C V B, Lind JG, Dillon-Carter O, et al. Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier. Brain Res [Internet]. 2004;1009:26–33.
   PubMed Web of Science ®Google Scholar
• Shen Q, Yin Y, Xia Q-J, et al. Bone marrow stromal cells promote neuronal restoration in rats with traumatic brain injury: involvement of GDNF regulating BAD and BAX Signaling. Cell Physiol Biochem [Internet]. 2016;38:748–762.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Watson JJ, Shoemark DK, et al. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther [Internet]. 2013;138:155–175.
   PubMed Web of Science ®Google Scholar
• Deng Q-J, Xu X-F RJ. Effects of SDF-1/CXCR4 on the repair of traumatic brain injury in rats by mediating bone marrow derived mesenchymal stem cells. Cell Mol Neurobiol [Internet]. 2017;38(2):467–477.
   Web of Science ®Google Scholar
• Harting MT, Sloan LE, Jimenez F, et al. Subacute neural stem cell therapy for traumatic brain injury. J Surg Res [Internet]. 2009;153:188–194.
   PubMed Web of Science ®Google Scholar
• Gao J, Grill RJ, Dunn TJ, et al. Human neural stem cell transplantation-mediated alteration of microglial/macrophage phenotypes after traumatic brain injury. Cell Transplant [Internet]. 2016;25:1863–1877.
   PubMed Web of Science ®Google Scholar
• Haus DL, López-Velázquez L, Gold EM, et al. Transplantation of human neural stem cells restores cognition in an immunodeficient rodent model of traumatic brain injury. Exp Neurol [Internet]. 2016;281:1–16.
   PubMed Web of Science ®Google Scholar
• Chen T, Yu Y, Tang L-J, et al. Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in traumatic brain injury sites. Neural Regen Res [Internet]. 2017;12:433–439.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Farooqui AA, Siddiqi NJ, et al. Effects of docosahexaenoic Acid on neurotransmission. Biomol Ther (Seoul) [Internet]. 2012;20:152–157.
   PubMed Web of Science ®Google Scholar
• Ghazale H, Ramadan N, Mantash S, et al. Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury. Behav Brain Res [Internet]. 2018;340:1–13.
   PubMed Web of Science ®Google Scholar
• Ramos-Zúñiga R, González-Pérez O, Macías-Ornelas A, et al. Ethical implications in the use of embryonic and adult neural stem cells. Stem Cells Int [Internet]. 2012;2012:470949.
   PubMedGoogle Scholar
• Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. Fischer A, Editor PLoS Med [Internet]. 2009;6:e1000029.
   PubMed Web of Science ®Google Scholar
• Cave JW, Wang M, Baker H. Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons. Front Neurosci [Internet]. 2014;8:16.
   PubMedGoogle Scholar
• Sullivan GM, Armstrong RC. Transplanted adult neural stem cells express sonic hedgehog in vivo and suppress white matter neuroinflammation after experimental traumatic brain injury. Stem Cells Int [Internet]. 2017;2017:9342534.
   PubMedGoogle Scholar
• Skardelly M, Gaber K, Burdack S, et al. Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences. Front Cell Neurosci [Internet]. 2014;8:318.
   PubMed Web of Science ®Google Scholar
• Bonilla C, Zurita M, Aguayo C, et al. Is the subarachnoid administration of mesenchymal stromal cells a useful strategy to treat chronic brain damage? Cytotherapy [Internet]. 2014;16:1501–1510.
   PubMed Web of Science ®Google Scholar
• Tajiri N, Acosta SA, Shahaduzzaman M, et al. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci [Internet]. 2014;34:313–326.
   PubMed Web of Science ®Google Scholar
• Mastro-Martínez I, Pérez-Suárez E, Melen G, et al. Effects of local administration of allogenic adipose tissue-derived mesenchymal stem cells on functional recovery in experimental traumatic brain injury. Brain Inj [Internet]. 2015;29:1497–1510.
   PubMed Web of Science ®Google Scholar
• Lam PK, Wang KKW, Lo AWI, et al. Interactome and reciprocal activation of pathways in topical mesenchymal stem cells and the recipient cerebral cortex following traumatic brain injury. Sci Rep [Internet]. 2017;7:5017.
   PubMed Web of Science ®Google Scholar
• Acosta SA, Tajiri N, Shinozuka K, et al. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. Ivanovic Z, Editor. PLoS One [Internet]. 2014;9:e90953. A.
   Web of Science ®Google Scholar
• Dela Peña I, Sanberg PR, Acosta S, et al. Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor. J Neurosurg Sci [Internet]. 2014;58:145–149.
   Google Scholar
• Kim D-W, Staples M, Shinozuka K, et al. Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci [Internet]. 2013;14:11692–11712.
   PubMed Web of Science ®Google Scholar
• Magatti M, Abumaree MH, Silini AR, et al. The immunomodulatory features of mesenchymal stromal cells derived from Wharton’s jelly, amniotic membrane and chorionic villi: in vitro and in vivo data. Placenta tree life. 2nd ed. Boca Raton, FL: CRC Press; 2016. p. 91–128.
   Google Scholar
• Hsieh J-Y-Y, Wang H-W-W, Chang S-J-J, et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. Shi X-M, Editor. PLoS One [Internet]. 2013;8:e72604.
   PubMed Web of Science ®Google Scholar
• Xiao B, Rao F, Guo Z-Y, et al. Extracellular matrix from human umbilical cord-derived mesenchymal stem cells as a scaffold for peripheral nerve regeneration. Neural Regen Res [Internet]. 2016;11:1172–1179.
   PubMed Web of Science ®Google Scholar
• Miyata S, Kitagawa H. Formation and remodeling of the brain extracellular matrix in neural plasticity: roles of chondroitin sulfate and hyaluronan. Biochim. Biophys. Acta [Internet]. 2017;1861:2420–2434.
   PubMed Web of Science ®Google Scholar
• Cheng T, Yang B, Li D, et al. Wharton’s jelly transplantation improves neurologic function in a rat model of traumatic brain injury. Cell Mol Neurobiol [Internet]. 2015;35:641–649.
   PubMed Web of Science ®Google Scholar
• Tajiri N, Kaneko Y, Shinozuka K, et al. Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. Daadi M, Editor. PLoS One [Internet]. 2013;8:e74857.
   PubMed Web of Science ®Google Scholar
• Shindo T, Matsumoto Y, Wang Q, et al. Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury. J Med Investig [Internet]. 2006;53:42–51.
   PubMedGoogle Scholar
• Neurogen B, Institute S Stem cell therapy in traumatic brain injury. 2010. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT02028104;
   Google Scholar
• The University of Texas Health Science Center H, Disorders NI of N, Stroke. Pediatric autologous bone marrow mononuclear cells for severe traumatic brain injury. 2013. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01851083;
   Google Scholar
• The University of Texas Health Science Center H. Safety of autologous stem cell treatment for traumatic brain injury in children. 2006. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT00254722;
   Google Scholar
• The University of Texas Health Science Center H. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01575470;
   Google Scholar
• Miao X, Wu X, Shi W. Umbilical cord mesenchymal stem cells in neurological disorders: a clinical study. Indian J Biochem Biophys [Internet]. 2015;52:140–146.
   PubMed Web of Science ®Google Scholar
• Wang Z, Luo Y, Chen L, et al. Safety of neural stem cell transplantation in patients with severe traumatic brain injury. Exp Ther Med [Internet]. 2017;13:3613–3618.
   PubMed Web of Science ®Google Scholar
• Disorders NI of N, Stroke, Center NI of HC. Effect of recombinant erythropoietin on numbers of circulating endothelial progenitor cells in people with persistent symptoms during the subacute period after traumatic brain injury. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT02226848;
   Google Scholar
• Liao GP, Harting MT, Hetz RA, et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med [Internet]. 2015;16:245–255.
   PubMed Web of Science ®Google Scholar
• Cox CS, Hetz RA, Liao GP, et al. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells [Internet]. 2017;35:1065–1079.
   PubMed Web of Science ®Google Scholar
• Sharma A, Sane H, Kulkarni P, et al. Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study. Springerplus [Internet]. 2015;4:26.
   PubMedGoogle Scholar
• Sharma A, Sane H, Kulkarni P, et al. Effect of cell transplantation in a chronic case of traumatic brain injury. Transplant. Open [Internet]. 2017;2:1–4.
   Google Scholar
• Hefferan MP, Johe K, Hazel T, et al. Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS. Cell Transplant. [Internet]. 2011;20:1153–1161.
   PubMed Web of Science ®Google Scholar
• Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells [Internet]. 2012;30:1144–1151.
   PubMed Web of Science ®Google Scholar
• Murcia F para la F e IS de la R de, III I de SC, Arrixaca HUV de la, et al. Clinical trial on the use of autologous bone marrow stem cells in amyotrophic lateral sclerosis (Extension CMN/ELA). 2010. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01254539;
   Google Scholar
• Corestem I. Safety and efficacy study of autologous bone marrow derived stem cell treatment in amyotrophic lateral sclerosis. 2011. [cited 2018 Jan 30]. Available from:https://ClinicalTrials.gov/show/NCT01363401;
   Google Scholar
• Neuralstem Inc. Dose escalation and safety study of human spinal cord derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis. 2013. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01730716;
   Google Scholar
• Nizzardo M, Bucchia M, Ramirez A, et al. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models. Hum Mol Genet [Internet]. 2016;25:3152–3163.
   PubMed Web of Science ®Google Scholar
• Zhong S-J, Gong Y-H, Lin Y-C. Combined intranasal nerve growth factor and ventricle neural stem cell grafts prolong survival and improve disease outcome in amyotrophic lateral sclerosis transgenic mice. Neurosci Lett [Internet]. 2017;656:1–8.
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Gross SK, Almad AA, et al. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Exp Neurol [Internet]. 2017;289:96–102.
   PubMed Web of Science ®Google Scholar
• Martínez HR, González-Garza MT, Moreno-Cuevas J, et al. Long-term survival in amyotrophic lateral sclerosis after stem cell transplantation into the frontal motor cortex. Cytotherapy [Internet]. 2016;18:806–808.
   PubMed Web of Science ®Google Scholar
• Pomeranian Medical University Szczecin. Biological treatment of amyotrophic lateral sclerosis. 2010. [cited 2018 Jan 30]. Availabe from: https://ClinicalTrials.gov/show/NCT02193893;
   Google Scholar
• Brain N, Institute S Stem cell therapy for amyotrophic lateral sclerosis. 2008. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01984814;
   Google Scholar
• Forces GH of CAP. The clinical trial on the use of umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01494480;
   Google Scholar
• Neuralstem Inc. Human spinal cord derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis. 2009. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01348451;
   Google Scholar
• The First Affiliated Hospital of Dalian Medical University. Transplantation of autologous peripheral blood mononuclear cells for amyotrophic lateral sclerosis. 2010. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT03085706;
   Google Scholar
• Li X-Y, Liang Z, Han C, et al. Transplantation of autologous peripheral blood mononuclear cells in the subarachnoid space for amyotrophic lateral sclerosis: a safety analysis of 14 patients. Neural Regen Res [Internet]. 2017;12:493–498.
   PubMed Web of Science ®Google Scholar
• Hospital Universitario Gonzalez JE. Effect of intrathecal administration of hematopoietic stem cells in patients with Amyotrophic Lateral Sclerosis (ALS). 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01933321;
   Google Scholar
• Hospital IA. Mesenchymal stem cell injection in amyotrophic lateral sclerosis. 2015. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT02116634;
   Google Scholar
• Clinic M. A dose-escalation safety trial for intrathecal autologous mesenchymal stem cell therapy in amyotrophic lateral sclerosis. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01609283;
   Google Scholar
• Clinic M. Mesenchymal stem cells for treatment of Amyotrophic Lateral Sclerosis (ALS). 2010. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01142856;
   Google Scholar
• Syková E, Rychmach P, Drahorádová I, et al. Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of Phase I/IIa clinical trial. Cell Transplant. [Internet]. 2017;26:647–658.
   PubMed Web of Science ®Google Scholar
• Staff NP, Madigan NN, Morris J, et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology [Internet]. 2016;87:2230–2234.
   PubMed Web of Science ®Google Scholar
• Azienda Ospedaliera Santa Maria, Terni I, Azienda Ospedaliero Universitaria Maggiore della Carita, Italy U di P. Human neural stem cell transplantation in Amyotrophic Lateral Sclerosis (ALS). 2011. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01640067;
   Google Scholar
• Nafissi S, Kazemi H, Tiraihi T, et al. Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: a safety and feasibility study. J Neurol Sci [Internet]. 2016;362:174–181.
   PubMed Web of Science ®Google Scholar
• Hospital HUS, Corestem I Safety Study of HLA-haplo matched allogenic bone marrow derived stem cell treatment in amyotrophic lateral sclerosis. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01758510;
   Google Scholar
• Hadassah Medical Organization. Derivation of induced pluripotent stem cells from an existing collection of human somatic cells. 2008. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT00801333;
   Google Scholar
• Tehran University of Medical Sciences. The effect of GCSF in the treatment of ALS patients. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01825551; 2012.
   Google Scholar
• Karussis D, Grigoriadis S, Polyzoidou E, et al. Neuroprotection in multiple sclerosis. Clin Neurol Neurosurg [Internet]. 2006;108:250–254.
   PubMed Web of Science ®Google Scholar
• Razavi S, Ghasemi N, Mardani M, et al. Co-transplantation of human neurotrophic factor secreting cells and adipose-derived stem cells in rat model of multiple sclerosis. Cell J [Internet]. 2018;20:46–52.
   Google Scholar
• Mahfouz MM, Abdelsalam RM, Masoud MA, et al. The neuroprotective effect of mesenchymal stem cells on an experimentally induced model for multiple sclerosis in mice. J Biochem Mol Toxicol [Internet]. 2017;31(9).
   Web of Science ®Google Scholar
• Wang X, Kimbrel EA, Ijichi K, et al. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports [Internet]. 2014;3:115–130.
   PubMed Web of Science ®Google Scholar
• Marin-Bañasco C, Benabdellah K, Melero-Jerez C, et al. Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis. Br J Pharmacol [Internet]. 2017;174:238–253.
   PubMed Web of Science ®Google Scholar
• Donders R, Vanheusden M, Bogie JFJ, et al. Human Wharton’s Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis. Cell Transplant. [Internet]. 2015;24:2077–2098.
   PubMed Web of Science ®Google Scholar
• Li J-F, Zhang D-J, Geng T, et al. The Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells as a Novel Cellular Therapy for Multiple Sclerosis. Cell Transplant. [Internet]. 2014;23:113–122.
   PubMed Web of Science ®Google Scholar
• Karnell FG, Lin D, Motley S, et al. Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation. Clin Exp Immunol [Internet]. 2017;189:268–278.
   PubMed Web of Science ®Google Scholar
• Muraro PA, Pasquini M, Atkins HL, et al. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol [Internet]. 2017;74:459–469.
   PubMed Web of Science ®Google Scholar
• Feasibility BT Study of human umbilical cord tissue-derived mesenchymal stem cells in patients with multiple sclerosis. 2014. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT02034188;
   Google Scholar
• Jordan U of. Safety and efficacy study of autologus bone marrow mesenchymal stem cells in multiple sclerosis. 2012. [cited 2018 Jan 30]. Available from: https://ClinicalTrials.gov/show/NCT01895439;
   Google Scholar
• Lee PH, Lee JE, Kim H-S, et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol [Internet]. 2012;72:32–40.
   PubMed Web of Science ®Google Scholar
• Na Kim H, Yeol Kim D, Oh S H, et al. Feasibility and efficacy of intra-arterial administration of mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy. Stem Cells Transl Med [Internet]. 2017;6:1424–1433.
   PubMed Web of Science ®Google Scholar
• Edelstein SAHLP. Seeking novel treatments abroad. stem cell tourism: risks, legal issues and mitigation. STEMSO Conf. 20142(1):e700.
   Google Scholar
• California’s Stem Cell Organization. Patient advisory for stem cell therapy and medical tourism [Internet]. Oakland, CA: California Institute for Regenerative Medicine. 2013.
   Google Scholar
• Council I of M and NR. Stem cell therapies [Internet]. Washington, D.C.: National Academies Press; The Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research. 2014.
   Google Scholar
• Reyes S, Tajiri N, Borlongan CV. Developments in intracerebral stem cell grafts. Expert Rev Neurother [Internet]. 2015;15:381–393.
   PubMed Web of Science ®Google Scholar
• Emborg ME, Zhang Z, Joers V, et al. Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant. [Internet]. 2013.
   PubMed Web of Science ®Google Scholar
• Lévêque X, Mathieux E, Nerrière-Daguin V, et al. Local control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation. J Cell Mol Med [Internet]. 2015;19(1):124–134.
   PubMed Web of Science ®Google Scholar
• Barkholt L, Flory E, Jekerle V, et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints. Cytotherapy [Internet]. 2013;15:753–759.
   PubMed Web of Science ®Google Scholar
• Acosta SA, Tajiri N, Hoover J, et al. Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke. Stroke [Internet]. 2015;46:2616–2627.
   PubMed Web of Science ®Google Scholar
• Vaquero J, Zurita M, Bonilla C, et al. Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury. Cytotherapy [Internet]. 2017;19:88–94.
   PubMed Web of Science ®Google Scholar
• Oppliger B, Joerger-Messerli M, Mueller M, et al. Intranasal delivery of umbilical cord-derived mesenchymal stem cells preserves myelination in perinatal brain damage. Stem Cells Dev [Internet]. 2016;25:1234–1242.
   PubMed Web of Science ®Google Scholar
• Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int [Internet]. 2013;130763.
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Hara K, Maki M, et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab [Internet]. 2008;28:1804–1810.
   PubMed Web of Science ®Google Scholar
• De La Pena I, Pabon M, Acosta S, et al. Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis. Cell Med [Internet]. 2014;6:123–127.
   PubMedGoogle Scholar